Results:
The MIE and open groups were similar in terms of gender (75% male in both groups) and average age (61 vs. 62 years, respectively). The majority of patients in the open group underwent neoadjuvant chemoradiation therapy (81%) due to institutional preferences at the time; a significantly smaller (43%) number of patients in the MIE group underwent neoadjuvant therapy (p<0.0001). In terms of oncologic efficacy, 97%
and 94% of patients in both groups underwent R0 resections. Patients undergoing MIE had a significant increase in the number of harvested LN (median=20 vs. 9 nodes, p<0.0001). Pathologic stage was similar between both groups. Length of stay was significantly decreased in patients who underwent MIE (8.5 days vs. 16 days, p=0.002).
Finally, there were significantly fewer serious complications (grades [3] [4] [5] in the MIE group (19% vs. 48%, p=0.0008).
Conclusions: In this initial report of a growing single-institution series of MIE, we
demonstrate that oncologic efficacy, in terms of completeness of resection and number of harvest LN is not compromised with this approach, and may actually be improved with a significantly increased number of harvested LNs. We also demonstrate this approach is associated with fewer serious complications and significant decrease in the length of postoperative hospital stay.
INTRODUCTION
Esophageal cancer is the eighth most common cause of cancer worldwide 3 . In 2010, it is estimated that there will be 16,640 new cases diagnosed in the U.S. and 14,500 deaths 1 . It often presents at an advanced stage and therefore tends to be incurable. For resectable disease, surgery is the gold standard for treatment. For these patients, who
often have considerable co-morbid conditions (obesity, smoking, and diabetes), esophagectomy carries a significant risk of perioperative morbidity and mortality.
Mortality rates range from 5-20% 2,3 and morbidity generally occurs in approximately 50% of patients 3 . Many series also report higher rates of complications with transthoracic esophagectomy compared to transhiatal esophagectomy 4 .
The minimally invasive approach to esophagectomy was first reported by 
METHODS

Patient Population
We queried our IRB-approved prospective esophagectomy database for patients 
Surgical Technique for '3-hole' MIE
Thoracoscopic Portion
The A mid-axillary 12-mm port is inserted in the right subcostal position. Using these ports, the greater curvature of the stomach is mobilized, with fastidious preservation of the gastroepiploic arcade. The short gastric vessels are divided and the fundus is mobilized.
The greater omentum is divided along the gastroepiploic arcade and the stomach is completely mobilized down to the origin of the right gastroepiploic arterial system. The lesser curve is then mobilized and the right diaphragmatic crus identified. The phrenoesophageal ligament is incised and the retrocardia space is established. The right crus is opened by incising it with the Harmonic scalpel to allow for easy placement of the conduit. At this point, the left gastric artery is divided with the endovascular GIA stapler, and the nodal tissue is swept up with the specimen. Next, the 12 mm port site is enlarged
to an approximately 5 cm incision and a Lap Disk wound protector is inserted.
Neck incision and completion
The left neck is approached through an oblique incision paralleling the anterior French red rubber catheter is placed laparoscopically as a feeding jejunostomy tube.
Synopsis of surgical technique for Ivor-Lewis MIE
The operation is begun with the patient in relaxed lithotomy position and the laparoscopic portion is performed as above. At the completion, the conduit is placed back into the abdominal cavity in the correct orientation so that it can be delivered into the chest for the next portion. The patient is then placed in the right lateral decubitus position and VATS ports are placed as above. The dissection proceeds as previously described except for that done towards the thoracic inlet. Once the esophagus is dissected circumferentially to the level of the azygous vein, it is sharply divided at this level and removed through a slightly enlarged posterior surgeon's port (#2, above).
At this point, a 29 EEA anvil is placed inside the esophagus. An EndoStitch is used to create a pursestring to secure the anvil in the esophageal lumen. The conduit is grasped and opened so that the EEA shaft can be placed into it. The spike from the EEA is brought out from the side of the conduit and docked into the anvil. The EEA is then fired and removed. At this point, an Endo GIA blue load is used to amputate that tip of the stomach and remove it from the chest. Another EndoStitch is used to tack the stomach to the diaphragmatic crura. The intercostal nerve block and chest tube placement proceed as described above.
RESULTS
Demographics (Table 1)
The groups were relatively equally matched in terms of demographic data ( Table   1 ). The average age in the open group was slightly higher at 62 years although this was not a significant difference (p=0.6). The majority of patients in both groups were male.
Finally, the vast majority of patients in the minimally invasive group (94%) had adenocarcinoma (n=55) or high-grade dysplasia (n=5), which reflects recent trends at TJUH where it is rare to see a patient with squamous cell carcinoma of the esophagus and even rarer for them to undergo esophagectomy. There were significantly more patients in open group who underwent neoadjuvant chemoradiation (81% vs. 43%). Finally, the patients were well distributed by pathologic stage-about 30% of patients in both groups had a stage 0 tumor. The majority of these were patients who had pathologic complete response to neoadjuvant chemoradiation.
Type of Surgery
In the minimally invasive group (n=65), there were eleven patients who underwent VATS with laparotomy and an anastomosis in the neck. Some of these patients were early in our experience (most in 2004 and 2005). There were also five patients who were intended to have MIE but the abdominal portion was unable to be completed laparoscopically due to severe adhesions from previous abdominal surgery.
The majority of patients in the MIE group (n=52) underwent both a thoracoscopic and a 
Perioperative Complications (Table 2)
There were five perioperative deaths (8%) in the MIE and four (8%) in the open group. This difference was not statistically significant. Of the five deaths in the MIE cohort, one was a sudden, unexplained, death on post-operative day one; the other four patients developed pneumonia and respiratory failure, which led to their demise. Of these five deaths in the MIE cohort, there were three deaths in the laparoscopy/thoracoscopy group (6%) and two deaths in the thoracoscopy/laparotomy group (18%). In the open group, the four patients who died suffered from gastric conduit necrosis, ischemic bowel, ARDS, and pneumonia/respiratory failure (one each). In terms of overall complications ( groups. The most common minor complications were wound infections and supraventricular arrhythmia; there were no significant differences between groups for these minor complications.
Surgical Outcomes (Table 3) The average blood loss was significantly lower for patients who underwent MIE as compared to those who had open surgery (182 vs. 619ml, p<0.0001). Additionally, the median length of stay (9 vs. 16 days) was significantly less in patients who underwent the minimally invasive approach (p=0.003). The R0 resection rates were high in both groups, and there were no differences between the groups. All five of the R1 resections consisted of the circumferential margins being positive and not margins on the esophagus or stomach themselves. Finally, we did note a significant increase in nodal harvest in the MIE group (median-20 vs. 9, p<0.0001). When laparoscopic colectomy for cancer was first introduced, there was a concern about port-site recurrences and oncologic efficacy 12, 13 . However, several randomized prospective trials demonstrated that the laparoscopic approach was not only safe, but oncologically sound. The COST trial (n=872) demonstrated equivalent nodal yields, recurrence-free, and overall survival with shorter hospital stay and decreased narcotic use in patients with colon cancer 14 . The COLOR trial from Europe (n=1248) also demonstrated equivalent nodal yields and margin positive resections 15 . Finally, in an analysis of NSQIP data, Bilimoria et al demonstrated that laparoscopic colectomy was associated with a significantly decreased rate of any complication and length of stay 16 .
DISCUSSION
In retrospect, early concerns about port-site recurrences and oncologic efficacy now appear unfounded. Therefore, in conclusion, we demonstrate that minimally invasive approaches to esophagectomy offer several advantages over open ones. These include decreases in the number of major complications, respiratory complications, blood loss and length of stay.
At the same time, oncologic efficacy is maintained with equivalent R0 resection rates, and significantly increased nodal yields. It is our feeling that the minimally invasive approach is justified for patients with esophageal cancer, and is safe even in patients who have received neoadjuvant therapy. Future study will need to determine the impact of these approaches on survival.
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